Press Releases Mangoceuticals, Inc.

Equities

MGRX

US56270V1061

Real-time Estimate Cboe BZX Other stock markets 12:34:04 01/06/2024 am IST			5-day change	1st Jan Change
0.407 ^USD	-1.93%		-2.68%	+44.53%

21/05	Sector Update: Health Care Stocks Advance Late Afternoon	MT
21/05	Sector Update: Health Care	MT

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Mangoceuticals, Inc. Announces Completion of First Batch of Mango ED Products for Marketing and Distribution in Mexico and Latin American Markets	28/05	AQ
MangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing Efforts	23/05	AQ
MangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 Medications	21/05	AQ
MangoRx Reports Revenue Growth of 108% in Q1 2024 Fueled by Amplified Customer Acquisition and Early Market Penetration	17/05	AQ
Mangoceuticals Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement and Conditional Approval of Compliance with Nasdaq’s Minimum Stockholders’ Equity Requirement	02/05	AQ
Mangoceuticals Acquires Global Patent Portfolio to Revolutionize Preventive Care	25/04	AQ
Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) Products	12/04	AQ
MangoRx Officially Launches ‘PRIME’ by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Treatment	12/03	AQ
MangoRx Launches Direct-To-Clinics Sales Division to Drive and Fuel Customer Acquisition and Revenue Growth	20/02	AQ
MANGORX AWARDS SAN FRANCISCO TEAM FREE MANGORX ED PRODUCTS FOR ONE YEAR FOLLOWING BIG GAME LOSS TO KANSAS CITY	13/02	AQ
MANGORX TO OFFER THE BIG GAME’S LOSING TEAM A FREE ONE YEAR SUPPLY OF ITS ED PRODUCT, MANGO, TO HELP RAISE… SPIRITS	06/02	AQ
MangoRx Accepting Pre Orders for its “PRIME”, by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Product	05/02	AQ
MangoRx’s Brand and Products to be Featured by Barstool Sports in Week of Programming Around the Biggest Sports Event of the Year on February 11	19/01	AQ
Mangoceuticals (MGRX) Blazes New Trails in Men's Health: Expands Global Reach and Innovates with Strategic Partnerships and Public Offering	29/12	AQ
Mangoceuticals (MGRX) Charting New Frontiers in Men's Health and Telemedicine Innovation	27/12	AQ
Mangoceuticals Inc (MGRX) Expands Its Horizons: A Deep Dive into Recent Developments	21/12	AQ
Mangoceuticals ($MGRX) Poised for Growth: Strategic Expansion and Public Offering Set Stage for Market Surge	19/12	AQ
Mangoceuticals, Inc. Announces Pricing of $1,200,000 Public Offering	15/12	AQ
InvestorBrandMedia: Mangoceuticals ($MGRX) Partners with Marius Pharmaceuticals: A Strategic Leap in Men's Health Market	14/12	AQ
MANGOCEUTICALS TO INTRODUCE “PRIME”, POWERED BY KYZATREX®️ (CIII TESTOSTERONE UNDECANOATE CAPSULES), FOR AN FDA APPROVED ORAL TESTOSTERONE REPLACEMENT THERAPY (TRT) PRODUCT	13/12	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Mangoceuticals, Inc.

Equities

MGRX

US56270V1061

Press Releases

Filters